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U.S. EPA’s Final Rule to create new management 
standards for hazardous waste (HW) 
pharmaceuticals was published in the Federal 
Register Feb. 22, 2019 and will become effective 
in Iowa on Aug. 21, 2019.  Healthcare facilities 
and reverse distributors must comply with the 
new Subpart P rule which is designed to 
improve and clarify regulation of HW 
pharmaceuticals.  
 
SUBPART P 
 The new rule, Subpart P, defines and regulates 
two different entities: healthcare facilities and 
reverse distributors. The rule defines a 
Healthcare Facility as any person that is lawfully 
authorized to: 
1. Provide preventative, diagnostic, therapeutic, 
rehabilitative, maintenance or palliative care, 
and counseling, service assessment or 
procedure with respect to the physical or 
mental condition, or functional status, of a 
human or animal or that affects the structure 
or function of the human or animal body; or 
2. Distribute, sell, or dispense pharmaceuticals, 
including over-the-counter pharmaceuticals, 
dietary supplements, homeopathic drugs, or 
prescription pharmaceuticals.  
 
Healthcare facilities are subject to two different 
sets of standards when managing HW 
pharmaceuticals, based on whether the 
pharmaceuticals are “potentially creditable” or 
“non-creditable.” 
POTENTIALLY CREDITABLE HW 
PHARMACEUTICALS are prescription HW 
pharmaceuticals that have a reasonable expectation 
of receiving manufacturer credit and is  
 1) In original manufacturer packaging,  
 2) Un-dispensed, and  
 3) Unexpired (or less than one year past its 
expiration date).  
This rule allows healthcare facilities to send 
potentially creditable hazardous waste 
pharmaceuticals to reverse distributors, provided 
they meet the minimal requirements in §266.502(a), 
§266.503 and §266.509.  
 
NON-CREDIBLE HW PHARMACEUTICALS are 
prescription HW pharmaceuticals that do not have a 
reasonable expectation to be eligible for 
manufacturer credit or a nonprescription HW 
pharmaceutical that does not have a reasonable 
expectation to be legitimately used/reused or 
reclaimed. These pharmaceuticals will typically be 
sent to a designated Treatment Storage Disposal 
(TSD) facility and must be managed by healthcare 
 facilities in accordance with §266.502 and §266.508 
requirements.  
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REVERSE DISTRIBUTORS are entities that 
receive potentially creditable HW 
pharmaceuticals from healthcare facilities and 
evaluate them to determine if they are eligible for 
manufacturer credit. The new rule allows reverse 
distributors to accept these HW pharmaceuticals 
from offsite without a Resource Conservation and 
Recovery Act (RCRA) permit as long as they 
comply with the requirements in §266.510.  
 
 
REVERSE LOGISTICS – nonprescription 
pharmaceuticals that are sent through reverse 
logistics are not wastes at the healthcare or retail 
facility IF they have a reasonable expectation of being 
lawfully used or reused for their intended purpose or 
reclaimed.  Reverse Logistics Centers are designed to: 
 Evaluate unsold retail items including 
nonprescription pharmaceuticals. 
 Analyze secondary markets. 
 Access the suitability of the unsold retail items 
for reuse in those secondary markets.  
REVERSE DISTRIBUTION REVERSE LOGISTICS 
Prescription  pharmaceuticals - Reverse Distributors 
(RD) are designed to: 
 Receive shipments of unused or expired 
prescription pharmaceuticals from healthcare 
facilities and, on behalf of manufacturers, 
facilitate the process of crediting healthcare 
facilities for these unused pharmaceuticals.  
 Prescription pharmaceuticals at RD are not 
reused nor resold and are discarded.  
 
Non-Prescription  pharmaceuticals 
 e.g., over –the-counter (OTC)  and dietary 
supplements 
All other unsold retail items.  
Reverse Logistic centers are designed to: 
 Evaluate unsold retail items, including 
nonprescription pharmaceuticals. 
 Analyze secondary markets. 
 Assess the suitability of the unsold retail 
items for reuse in those secondary 
markets.  
 
No redistribution occurs. Redistribution sometimes occurs via: 
 Donation 
 Liquidation (secondary market)  
 
Prescription pharmaceuticals sent to reverse 
distributors are solid waste at the healthcare facility. 
Non-Prescription pharmaceuticals and other 
unsold retail items sent to reverse logistics are not 
solid waste if there is a reasonable expectation of 
legitimate use/reuse or reclamation.  
 
In Part 266 Subpart P, which is effective in Iowa 
August 2019. 
Newly codified in part 266 Subpart P, effective in 
Iowa August 2019. 
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*Triple rinsing of containers with acute     
hazardous waste pharmaceuticals is no longer 
allowed.  
EMPTY CONTAINER STANDARDS            
 §261.7 / § 266.507 
 RCRA EMPTY 
Non-acute HW 
pharms 
Acute HW 
pharms* 
Stock/Dispensing 
bottles (1 liter or 
10,000 pills and 
unit-dose 
containers) 
Remove contents Remove 
contents 
Syringes Fully depress 
plunger 
Fully depress 
plunger 
 
IV Bags Fully administer 
contents or 
261.7(b)(1) 
 
Fully 
administer 
contents 
Other Containers 261.7(b)(1) or (2) Cannot be 
RCRA empty 
 
SEWERING PROHIBITION 266.505 
The final rule prohibits the sewering (e.g., by pouring them into a 
sink, toilet or floor drain) of HW pharmaceuticals by all healthcare 
facilities and reverse distributors, including those that qualify as 
Very Small Quantity Generators (VSQGs). This does not apply to 
non-hazardous waste pharmaceutical or households, but the 
Environmental Protection Agency (EPA) strongly recommends 
against sewering any pharmaceuticals by any entity. 
     EMPTY CONTAINER PROVISION 
The final rule amends the definition of Resource     
Conservation and Recovery Acts (RCRA) empty 
container in relation to HW pharmaceuticals and 
further requires for managing containers with 
remaining residues. Stock, dispensing and unit-
dose containers (not exceeding 1 liter or 10,000 
pills) will be considered RCRA-empty if the 
pharmaceuticals have been removed using 
standard practices employed to remove 
materials from that type of container.  Syringes 
will be regarded as empty if the contents have 
been removed by fully depressing the plunger of 
the syringes. IV bags will be considered empty 
provided the pharmaceuticals in the IV bag have 
been fully administered to the patient. The 
details vary depending on the specific type of 
container and can be read in detail at §266.507.   
 
Hazardous Waste Pharmaceuticals and Amendment 
to the Nicotine Listing (P075) Final Rule 
 
 
 
www.iowadnr.gov 
Iowa Department of Natural Resources  |  502 E. 9th St. Des Moines, IA 50319  |  515-725-8200 
www.iowadnr.gov 
 
 
.  
 
 
 
 
 
 
SUMMARY MATRIX OF PART 266 SUBPART P 
 Standards for  
Healthcare Facilities 
Standards for  
Reverse Distributors 
 POTENTIALLY CREDITABLE 
 
POTENTIALLY CREDITABLE 
On-site accumulation  No standards 
 No time limit 
          Evaluate within 30 days 
Shipping to a reverse 
distributor 
 Confirmation of delivery 
 Common carrier 
 Confirmation of delivery 
 Common carrier 
 NON-CREDITABLE 
 
EVALUATED 
On-site accumulation  UW-like standards 
 1 year maximum  
 LQG-like standards 
 180 days after evaluation 
Shipping to a Treatment 
Storage Disposal Facility 
(TSDF) 
 Manifest (PHARMS) 
 HW transporter 
 Manifest (waste codes) 
 HW transporter 
This fact sheet contains key highlights of the final rule. For a more detailed summary of the rule, 
please visit: www.epa.gov/hwgenerators/final-rule-management-standards-hazardous-waste-
pharmaceuticals-and-amendment-p075 
 
NICOTINE P075 REVISION 
The P075 listing for nicotine is being amended 
such that Food and Drug Administration 
approved over-the-counter (OTC) nicotine 
replacement therapies will no longer be included 
under the P075 listing for HW. Thus nicotine 
patches, gums and lozenges can be discarded as 
non-hazardous waste.  
Other unused formulations of nicotine will still be 
consi red P0          considered P075 when discarded including: 
 E-liquids/e-juices in e-cigarettes cartridges 
or vials.  
 Legacy pesticides containing Nicotine. 
 Nicotine used in research and 
manufacturing. 
E-liquids/e- in e-  
 .  
 
